Navigation Links
John C. Moran Named Chairman of the Board at Core Essence Orthopaedics
Date:4/7/2009

YARDLEY, Pa., April 7 /PRNewswire/ -- Core Essence Orthopaedics, Inc., a medical device company focused on soft tissue and skeletal repair of the extremities, today announced that John Moran has joined Core Essence as Chairman of the Board, effective immediately. Moran joins Directors Tony Dimun, Leonard Gordon, M.D., Shawn Huxel and Zev Scherl.

"We are thrilled to welcome a proven leader like John as our board's Chairman," said Shawn Huxel, co-founder and Chief Executive Officer of Core Essence. "John brings nearly 30 years of experience as an executive and investor in the medical device industry to Core Essence. We look forward to his insight and counsel as Core Essence prepares for the commercial launch of its novel portfolio of orthopaedic products over the coming months."

"Core Essence is at an exciting stage of its growth," explained John Moran, Chairman. "With our lead products now cleared for marketing by the FDA, Core Essence is well positioned to participate in the more than $1 billion market opportunity for orthopaedic soft tissue repair. It will be a pleasure to work with the Core Essence team and its Scientific Advisory Board as we commence commercial operations and embark on this next phase of growth."

From 1990-1997, Moran served as President of Synthes Spine Inc., a division of Synthes (USA) that designs, manufactures and distributes implants and instruments for spinal disorders. During Moran's six-year tenure as President, Synthes Spine's revenues grew from approximately $1 million to more than $60 million.

Moran has also been a board member for a number of companies, primarily in the medical device arena, including Spine Solutions, Inc., (the developer of ProDisc). Moran is currently on the board of Paradigm Spine, LLC, Ranier Technology, Anika Therapeutics , and Power Medical Interventions, Inc. Moran is a graduate of the University of Notre Dame and holds an MB
'/>"/>

SOURCE Core Essence Orthopaedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Campaign for Americas Future Memorandum: Katrina Storm Warning
2. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
3. DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India
4. Iraqs Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management
5. Intercim and Dassault Systemes Sign Memorandum of Understanding
6. Anita Moran AIA Joins WHR Dallas
7. UCLA signs historic memorandum with pediatric institution in Tokyo
8. Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard
9. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
10. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
11. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Diabetics at Greater Risk of Developing Dry Skin Infection 5818 1Diabetics at Greater Risk of Developing Dry Skin Infection 5818 2Diabetics at Greater Risk of Developing Dry Skin Infection 5818 3Diabetics at Greater Risk of Developing Dry Skin Infection 5818 4PDI Inc to Hold Third Quarter 2009 Financial Results Conference Call on Thursday November 5 2009 5816 1PDI Inc to Hold Third Quarter 2009 Financial Results Conference Call on Thursday November 5 2009 5816 2CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 1CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 2CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 3CVS Caremarks MinuteClinic and Allina Hospitals 26amp 3B Clinics Form Strategic Partnership 5814 4